We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$836M
AUM Growth
+$186M
Cap. Flow
+$173M
Cap. Flow %
20.65%
Top 10 Hldgs %
29.89%
Holding
597
New
223
Increased
13
Reduced
17
Closed
170

Top Buys

Rank Stock Value
1
ATIP
ATI Physical Therapy, Inc.
ATIP
+$22.4M
2
AVAH icon
Aveanna Healthcare
AVAH
+$20.8M
3
AGTI
Agiliti Inc
AGTI
+$16.7M
4
GENI icon
Genius Sports
GENI
+$16M
5
MYPS icon
PLAYSTUDIOS Inc
MYPS
+$14.5M

Top Sells

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$13.5M
2
SHC icon
Sotera Health
SHC
+$8.74M
3
PSFE icon
Paysafe
PSFE
+$8.13M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.83M
5
HQY icon
HealthEquity
HQY
+$6.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.03%
2 Financials 12.76%
3 Technology 11.06%
4 Industrials 8.14%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
51
X4 Pharmaceuticals
XFOR
$460M
$3.74M 0.45%
19,157
– –
DMS
52
DELISTED
Digital Media Solutions, Inc.
DMS
$3.71M 0.44%
18,187
-1,813
-9% -$298K
SWTX
53
DELISTED
SpringWorks Therapeutics
SWTX
$3.71M 0.44%
45,000
+10,000
+29% +$759K
OSW icon
54
OneSpaWorld
OSW
$2.66B
$3.63M 0.43%
+375,000
New +$4.1M
GHRS icon
55
GH Research
GHRS
$2.08B
$3.58M 0.43%
+165,000
New +$3.37M
PCPC
56
DELISTED
Periphas Capital Partnering Corporation
PCPC
$3.58M 0.43%
146,222
-3,766
-3% -$92.3K
AVIR icon
57
Atea Pharmaceuticals
AVIR
$420M
$3.54M 0.42%
+165,000
New +$4.96M
EARN
58
Ellington Residential Mortgage REIT
EARN
$165M
$3.53M 0.42%
+300,000
New +$3.71M
FSTX
59
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.44M 0.41%
+400,000
New +$3.41M
SGTX
60
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$3.41M 0.41%
+24,420
New +$4.29M
ARCT icon
61
Arcturus Therapeutics
ARCT
$211M
$3.38M 0.4%
+100,000
New +$3.39M
UPH
62
DELISTED
UpHealth, Inc.
UPH
$3.37M 0.4%
+50,000
New +$4.7M
MNDY icon
63
monday.com
MNDY
$3.94B
$3.35M 0.4%
+15,000
New +$3.27M
INTA icon
64
Intapp
INTA
$2.91B
$3.28M 0.39%
+117,000
New +$3.28M
PMGM
65
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$3.16M 0.38%
324,996
– –
FLYW icon
66
Flywire
FLYW
$2.16B
$3.12M 0.37%
+85,000
New +$2.85M
CYT
67
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$3.1M 0.37%
+145,000
New +$2.72M
HYZN
68
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$3.09M 0.37%
6,000
– –
CXM icon
69
Sprinklr
CXM
$1.61B
$3.09M 0.37%
+150,000
New +$3.14M
APR
70
DELISTED
Apria, Inc. Common Stock
APR
$3.08M 0.37%
+110,000
New +$3.23M
WKME
71
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$3.07M 0.37%
+105,000
New +$3.12M
ENPC
72
DELISTED
Executive Network Partnering Corporation
ENPC
$3.04M 0.36%
312,490
– –
PSFE icon
73
Paysafe
PSFE
$375M
$3.03M 0.36%
20,833
-54,167
-72% -$8.13M
SNCE
74
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$3M 0.36%
+15,000
New +$3.05M
S icon
75
SentinelOne
S
$7.34B
$2.98M 0.36%
+70,000
New +$2.98M
1 2
3
4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Monashee Investment Management held 597 positions worth $836M, up 29% from $650M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Monashee Investment Management deployed $173M of net new capital in Q2 2021, opening 223 new positions and adding to 13 existing holdings. Its largest new stake was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Beam Therapeutics, an estimated $13.5M trimmed.

  • Monashee Investment Management's largest Q2 2021 buy was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.
  • Monashee Investment Management added most to PLAYSTUDIOS Inc in Q2 2021, an estimated $14.5M increase.
  • Monashee Investment Management's biggest Q2 2021 reduction was Beam Therapeutics, cutting an estimated $13.5M.
  • Monashee Investment Management fully exited Sotera Health in Q2 2021, selling an estimated $8.74M.
  • Monashee Investment Management's ten largest holdings make up 30% of its $836M portfolio in Q2 2021.
  • Monashee Investment Management opened 223 new positions and closed 170 in Q2 2021.
  • Monashee Investment Management's portfolio value rose 29% quarter-over-quarter to $836M.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.